GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BerGenBio ASA (LTS:0RU5) » Definitions » Cash Receipts from Operating Activities

BerGenBio ASA (LTS:0RU5) Cash Receipts from Operating Activities


View and export this data going back to 2017. Start your Free Trial

What is BerGenBio ASA Cash Receipts from Operating Activities?

Cash Receipts from Operating Activities only applicable to companies reporting Cash Flow from Operations in direct method.


BerGenBio ASA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BerGenBio ASA (LTS:0RU5) » Definitions » Cash Receipts from Operating Activities
Traded in Other Exchanges
Address
Nygardsgaten 114, Bergen, NOR, 5008
BerGenBio ASA is a clinical-stage biopharmaceutical company developing drugs for aggressive diseases, including drug resistant and metastatic cancers and respiratory disease. Its product, bemcentinib (BGB324), is a selective, potent, oral small molecule AXL inhibitor that has been tested in a various indications including NSCLC, AML and severe respiratory infections.